Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Tennessee for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Tennessee only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Tennessee (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Rachel Robinson (NPI 1316531676)

Field	Value
Entity Type	Individual
Organization	Rachel Robinson
Address	700 W Forest Ave
City	Jackson
State	TN
ZIP	38301
Taxonomy	Family Nurse Practitioner
NPI Enumerated	February 25, 2021

Payer Source	Total Paid
Medicare	$2.1M
Medicaid	$0

Key Findings

This provider’s commercial footprint is effectively single-payer Medicare: total Medicare revenue is $2.1M while Medicaid shows none (no Medicaid billing on file). That concentration means Medicaid population exposure is negligible in the available billing data and Medicare reimbursement dynamics dominate the practice’s revenue profile.

Revenue is highly concentrated in a small set of high-cost injectable therapies: the precomputed top 3 Medicare codes account for 54.4% of the provider’s Medicare revenue, driven by J1569 ($387.8K, 18.6%), J1306 ($378.3K, 18.1%), and J2357 ($368.6K, 17.7%). This degree of concentration indicates that a handful of biologic and specialty drug lines underpin the majority of billed Medicare dollars.

The CPT/HCPCS mix indicates an in-office biologics/infusion and injection model rather than routine primary care. Leading codes include high-cost biologic J-codes such as J1569 (immune globulin), J1306 (inclisiran), J2357 (omalizumab) and additional biologics like J3245, J2182, J3380 and J0517, together with infusion/administration codes (96365, 96366, 96413), which is consistent with on-site preparation/administration of specialty injectables.

Competitive standing varies by product: for inclisiran (J1306) the provider ranks #24 of 462 nationally (95th percentile; notably above typical national volume for this code), marking them as a major national participant for that specific therapy. By contrast J1569 and J2357 each rank in the 92nd percentile (#45 of 542 and #49 of 581 respectively) and are described in the benchmark as typical/unremarkable volume, so the practice is high-volume for several agents but not broadly dominant across all biologics.

The practice shows at least one statistical volume outlier in administration activity: 96372 has 839 claims, $7.6K revenue and ranks #594 of 58224 (99th percentile; extreme outlier, far above typical national volume for this code). While 96372 contributes a small share of Medicare dollars relative to the top J-codes, the extreme claim volume suggests routine use of intramuscular/subcutaneous injections at scale, consistent with an injection-focused workflow.

Beyond the top three, the provider bills a broad set of specialty biologics across therapeutic areas—dermatology (J3245 tildrakizumab), pulmonology/allergy (J2182 mepolizumab, J0517 benralizumab, J2357 omalizumab), and gastroenterology (J3380 vedolizumab, J1745 infliximab). This diversity of J-codes implies the operation serves multiple specialty indications and likely coordinates specialty drug procurement and administration in-house.

Tenure is relatively recent: NPI enumerated on 2021-02-25 (~5 years ago), indicating the current billing profile and build-out of specialty services occurred within a comparatively short operating window. That timeline may be relevant when assessing scalability, contracting history, or recent shifts in service mix.

From a revenue-sensitivity perspective, dependence on a few high-revenue J-codes and sole reliance on Medicare ($2.1M) means changes to reimbursement, national uptake, or utilization patterns for those specific agents could materially affect overall revenue. Payers and competitors evaluating contracting or network strategy should note both the high revenue concentration (54.4% from top 3 codes) and the provider’s standout national position on select products like J1306 when estimating negotiation leverage or referral value.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

16 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	10,770	$40	$387.8K
J1306	Injection, inclisiran, 1 mg	42,030	$10	$378.3K
J2357	Injection, omalizumab, 5 mg	12,290	$30	$368.6K
J3245	Injection, tildrakizumab, 1 mg	3,000	$110	$330K
J2182	Injection, mepolizumab, 1 mg	10,300	$20	$236.9K
J3380	Injection, vedolizumab, intravenous, 1 mg	10,500	$20	$157.5K
J0517	Injection, benralizumab, 1 mg	900	$130	$119.7K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	2,850	$30	$74.1K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	210	$70	$15K
96372	A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician…	840	$10	$7.6K

Showing 1–10 of 16

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Tennessee Distribution

Rachel Robinson — 3 of 16 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Tennessee

Full comparison — all codes billed, vs. state median

16 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3245	9	20	3,800	$110	$405.5K
J3380	16	20	12,300	$20	$295.9K
J0517	10	10	1,200	$130	$215.6K
J2182	3	10	7,950	$20	$208.3K
J1569	5	30	3,030	$40	$175.2K
J2357	2	40	3,740	$30	$133.5K
J1745	24	40	3,270	$30	$116.4K
J1306	1	40	7,380	$10	$88.9K
96413	96	240	150	$90	$18.9K
96365	68	280	80	$40	$5.1K

Showing 1–10 of 16

Related Providers

Other providers that share a Tax Identification Number (TIN) with Rachel Robinson, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Jackson Madison County General Hospital	TN	General Acute Care Hospital	$0	$46.6M
Jackson-madison County General Hospital	TN	Land Ambulance	$5.1M	$13M
West Tennessee Medical Group Inc	TN	Internal Medicine Physician	$0	$8.2M
Jackson-madison County General Hospital	TN	Community/Retail Pharmacy	$0	$7.4M
Stephen Huddleston	TN	Retina Specialist (Ophthalmology) Physician	$5.7M	$0
Wt Medical Associates	TN	Rural Health Clinic/Center	$0	$5.5M
Wt Medical Associates	TN	Internal Medicine Physician	$0	$4.9M
Scott Sullivan	TN	Retina Specialist (Ophthalmology) Physician	$3M	$0
Wt Medical Associates	TN	Rural Health Clinic/Center	$0	$2.5M
Salar Rafieetary	TN	Retina Specialist (Ophthalmology) Physician	$2.1M	$0

Nearby Providers

Other providers in the same ZIP code as Rachel Robinson, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Pathways Of Tennessee, Inc.	TN	Clinic/Center	$0	$30.6M
Emergency Medical Care Facilities PC	TN	Emergency Medicine Physician	$0	$19.7M
A Plus Care Solutions Incorporated	TN	In Home Supportive Care Agency	$0	$18.4M
Mid-south Perinatal Associates PC	TN	Maternal & Fetal Medicine Physician	$0	$11.6M
Wt University Medical Associates Inc	TN	Family Medicine Physician	$0	$7.5M
Shavetta Conner	TN	Public Health & General Preventive Medicine Physician	$8.1K	$4.9M
West Tennessee Healthcare Hospitalists Inc	TN	Hospitalist Physician	$0	$4.3M
Home Medical Products, Inc.	TN	Oxygen Equipment & Supplies (DME)	$0	$3.6M
Pathways Of Tennessee, Inc.	TN	Psychiatric Hospital	$0	$3.3M
William Priester	TN	Ophthalmology Physician	$3.2M	$0

Rachel Robinson — Billing Profile & Reimbursement Data

Sign up for Rachel Robinson — Billing Profile & Reimbursement Data policy alerts

Rachel Robinson — Billing Profile & Reimbursement Data

Sign up for Rachel Robinson — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References